SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001192482-11-000041
Filing Date
2011-02-17
Accepted
2011-02-17 18:43:03
Documents
1
Period of Report
2011-02-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 7552
  Complete submission text file 0001192482-11-000041.txt   9536
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Issuer) CIK: 0001070336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104
Business Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104 (215) 988-6800
Quaker BioVentures II LP (Reporting) CIK: 0001497725 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33095 | Film No.: 11622170